Wei-Li Hsu | Immunology | Women Researcher Award

Published on by Innovation Technologist

Prof. Dr. Wei-Li Hsu | Immunology | Women Researcher Award

Professor and Director of Graduate Institute at National Chung Hsing University | Taiwan

Prof. Wei-Li Hsu is a distinguished academic and researcher with extensive expertise in molecular virology and veterinary medicine. Over the years, she has established himself as a leading scholar through his pioneering research, impactful publications, and academic leadership, contributing significantly to both fundamental science and applied biomedical research.

Professional Profile

Scopus

Google Scholar

Educational Background 

She holds a Ph.D. in Molecular Virology from the University of Glasgow, UK, building on a Master’s degree in Veterinary Microbiology and a Doctor of Veterinary Medicine degree from National Chung-Hsing University, Taiwan. This solid academic foundation provided him with interdisciplinary expertise spanning veterinary sciences and advanced virological research.

Professional Experience 

Prof. Hsu has built a long and distinguished career at National Chung-Hsing University (NCHU), Taiwan, where she progressed from Assistant Professor to Associate Professor, Professor, and later Distinguished Professor. She has also served in leadership roles such as Director of the Graduate Institute of Microbiology & Public Health and Associate Dean of the College of Veterinary Medicine. His international career includes postdoctoral research at the University of Alberta, Canada, and the University of Cambridge, UK, along with visiting professorships at the Tokyo University of Agriculture and Technology, Japan, and a visiting scholar appointment at the Icahn School of Medicine at Mount Sinai, USA.

Research Interests 

Her research centers on molecular virology, with a particular focus on influenza viruses, herpesviruses, and the use of viral vectors for therapeutic purposes. His work spans viral pathogenesis, immunogenicity, vaccine development, and the application of attenuated viruses as safe vectors for cancer treatment. She has also contributed to advancing virus-like particle production and the development of novel antiviral strategies.

Awards and Honors 

Prof. Hsu has been repeatedly recognized for his academic excellence. She has held the title of Distinguished Professor at National Chung-Hsing University across multiple terms and received the Outstanding Young Researcher Award from the same institution on several occasions. During his doctoral studies in the UK, she was awarded the prestigious Overseas Research Student Award and postgraduate scholarships from the University of Glasgow.

Research Skills 

She possesses advanced expertise in molecular virology, including viral vector engineering, immunological evaluation of viral antigens, vaccine development, and translational applications of virological research. In addition, his leadership and mentorship skills have enabled him to guide research teams, foster academic collaborations, and contribute to the development of future scientists.

Publication Top Notes

  • Inhibition of enveloped viruses infectivity by curcumin

  • Cited by: 203

  • Year: 2013

  • The first discovery of severe fever with thrombocytopenia syndrome virus in Taiwan

  • Cited by: 146

  • Year: 2020

  • Bovine lactoferrin inhibits Japanese encephalitis virus by binding to heparan sulfate and receptor for low density lipoprotein

  • Cited by: 113

  • Year: 2008

  • Urine neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute canine kidney injury

  • Cited by: 107

  • Year: 2012

  • Bovine lactoferrin inhibits dengue virus infectivity by interacting with heparan sulfate, low-density lipoprotein receptor, and DC-SIGN

  • Cited by: 97

  • Year: 2017

Conclusion 

Prof. Wei-Li Hsu’s career demonstrates a profound commitment to advancing knowledge in molecular virology and veterinary medicine. Through his outstanding research achievements, international collaborations, and leadership in higher education, she has made a lasting impact on science and global health. His work continues to bridge basic research and clinical applications, positioning him as a prominent figure in the field.

 

Prabhjyoti Pahwa | Immunology | Best Researcher Award

Published on by Innovation Technologist

Ms. Prabhjyoti Pahwa | Immunology | Best Researcher Award

Ph.D. Student at Institute of Liver and Biliary Sciences, India

Prabhjyoti Pahwa is a dedicated Ph.D. scholar at the Institute of Liver and Biliary Sciences, New Delhi, with a focus on immunology and liver diseases. Her work spans a wide range of research areas, from viral infections to immune-metabolic responses in liver disease pathogenesis. She has actively contributed to multiple peer-reviewed publications in leading journals, particularly exploring immune alterations in diseases like Hepatitis E and B, as well as in COVID-19 during pregnancy. As a researcher, she combines a strong technical skillset in molecular biology and cell biology with a passion for understanding the immune system’s role in liver diseases. Prabhjyoti is committed to advancing the field of hepatology through innovative research, with a vision to improve maternal and fetal health outcomes in viral infections.

Publication Profile : 

Scopus

Educational Background 🎓

  • Ph.D. (2022 – Present)
    Institute of Liver and Biliary Sciences, New Delhi
  • Junior Research Fellow (2020 – 2022)
    Institute of Liver and Biliary Sciences, New Delhi
  • M.Sc. in Biotechnology (2017 – 2019)
    Panjab University, Chandigarh
    GPA: 3.45 (86.24%)
  • B.Sc. in Zoology (Hons.) (2014 – 2017)
    Zakir Husain Delhi College, University of Delhi
    GPA: 3.199 (79.99%)
  • Intermediate (Class 12, 2014)
    RPVV Raj Niwas Marg, Delhi
    80.04%
  • Matriculation (Class 10, 2012)
    B.M. Ganges Girls’ Senior Secondary School, Delhi
    CGPA: 8.2

Professional Experience 💼

Prabhjyoti Pahwa is currently a Junior Research Fellow and Ph.D. Scholar at the Institute of Liver and Biliary Sciences (ILBS), New Delhi, where she has been conducting cutting-edge research on hepatology and immunology since 2020. Her research focuses on Hepatitis E Virus (HEV) infection during pregnancy and its severe maternal and fetal outcomes, as well as the immune-metabolic shifts in various liver diseases, including Hepatitis B and C. Throughout her research career, she has worked under the mentorship of Prof. Nirupama Trehanpati and collaborated with prominent researchers in the field of liver diseases. Previously, she was a Master’s student at Panjab University, Chandigarh, where she gained practical experience in biotechnology, cell biology, and molecular techniques. She has also worked on several collaborative projects, contributing to a diverse range of research topics, from lipase-producing bacteria to biosensors for pesticide detection.

Research Interests 🔬

Prabhjyoti’s primary research interests include:

  • Hepatitis E virus (HEV) and its impact during pregnancy
  • Immuno-metabolic shifts in liver diseases, especially in pregnant women with viral infections
  • The role of T cells, natural killer cells, and cytokines in the progression of liver diseases like hepatitis B
  • Single-cell RNA sequencing for exploring immune responses in chronic viral infections
  • Investigating metabolomic alterations and their correlation with disease severity in liver diseases and SARS-CoV-2 infections during pregnancy.

Publications 📚

  1. Prabhjyoti Pahwa, Deepti Sharma*, Pushpa Yadav, Sherin Sarah Thomas, Sandhya Hora, Preedia Babu E., Gayatri Ramakrishna, Shiv Kumar Sarin*, Nirupama Trehanpati*.
    Prognostic role of serum VEGF and HGF post SBRT in advanced hepatocellular carcinoma.
    Journal of Clinical and Experimental Hepatology, 2024 (Accepted in October 2024).

  2. Anoushka Saxena, Minal, Prabhjyoti Pahwa, Jaswinder Singh Maras, Hamda Siddiqui, Jayesh Kumar Sevak, Y.M. Mala, Shakun Tyagi, Shiv Kumar Sarin, Nirupama Trehanpati.
    Immuno-metabolic shifts in acute liver failure caused by hepatitis E virus infection during pregnancy and their association with obstetric outcomes.
    Hepatology Communication, 2024 (Accepted in October 2024).

  3. Prabhjyoti Pahwa, Ashish Kumar Vyas, Jayesh Kumar Sevak, Ravinder Singh, Jaswinder Singh Maras, Sharda Patra, Shiv K Sarin, Nirupama Trehanpati*.
    Modulation of CD8+ T cells, natural killer cells and Th1 cytokines by metabolic milieu in decline of HBV viremia in pregnant women treated with Tenofovir disoproxil from second trimester of pregnancy.
    Journal of Reproductive Immunology, 2024, Volume 162.

  4. Sandhya Hora$, Prabhjyoti Pahwa$, Hamda Siddiqui, Anoushka Saxena, Minal Kashyap, Jayesh Kumar Sevak, Ravinder Singh, Maryam Javed, Pushpa Yadav, Pratibha Kale, Gayatri Ramakrishna, Meenu Bajpai, Asmita Rathore, Jaswinder Singh Maras, Shakun Tyagi*, Shiv Kumar Sarin*, Nirupama Trehanpati*.
    Metabolic alterations unravel the materno–fetal immune responses with disease severity in pregnant women infected with SARS-CoV-2.
    Journal of Medical Virology, December 2023, Volume 95, Issue 12.
    DOI: 10.1002/jmv.29257.

  5. Prabhjyoti Pahwa1, Ravinder Singh1, Partha Chattopadhyay2, Priyanka Mehta2, Sharda Patra3, Rajesh Pandey2, Shakun Tyagi4, Shiv Kumar Sarin5*, Nirupama Trehanpati1*.
    Single cell RNA sequencing reveals exhausted adaptive immunity in utero to HBV exposed neonates born to mothers with high HBsAg titres persisting despite vaccination.
    Hepatology, AASLD 2024, Poster of Distinction.

  6. Prabhjyoti Pahwa, Fatima Ali, Ashish Kumar Vyas, Sharda Patra, Shiv K Sarin, Nirupama Trehanpati*.
    Decline in viral load induces CD8+ T cells, natural killer cells and Th1 cytokine profile in chronic hepatitis B infected pregnant women treated with Tenofovir disoproxil from second trimester.
    Oral Presentation, AASLD 2022.

  7. Anoushka Saxena, Hamda Siddiqui, Jayesh Kumar Sevak, Minal, Prabhjyoti Pahwa, Fatima Ali, Shakun Tyagi, Shiv Kumar Sarin, Nirupama Trehanpati*.
    IL-7 induced CD4+ Memory stem T cell-derived pro-inflammatory cytokine storm plays a role in hepatitis E induced pathogenesis in pregnant women.
    AASLD 2022.

  8. Anoushka Saxena, Minal Kashyap, Prabhjyoti Pahwa, Fatima Ali, Hamda Siddiqui, Preedia Babu E., Y.M. Mala, Shakun Tyagi, Nirupama Trehanpati.
    Elevated serum bilirubin levels and aminotransferases are associated with immuno-modulatory and suppressive subsets in pregnant females with intrahepatic cholestasis and hepatitis E virus infection.
    EASL 2022.

  9. Anoushka Saxena, Prabhjyoti Pahwa, Hamda Siddiqui, Jaswinder Singh Maras, Rashi Sehgal, Sharda Patra, Shiv Kumar Sarin, Nirupama Trehanpati.
    The metabolome profiling of patients infected with hepatitis E virus unravels the role of Nicotinate and Nicotinamide pathway and D-glutamine and glutamate metabolism in the development of Acute Liver Failure.
    AASLD 2021.

  10. Prabhjyoti Pahwa, Hamda Siddiqui, Fatima Ali, Jayesh Kumar Sevak, Archana Rastogi, Sakshi Aggarwal, Shakun Tyagi, Nirupama Trehanpati, Asmita Rathore.
    Rise in pro- and anti-inflammatory cytokines in asymptomatic and mild COVID-19 pregnant patients than moderate to severe patients.
    AOGD 2021.